×
About 700 results

ALLMedicine™ Alopecia Areata Center

Research & Reviews  262 results

Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Eve...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752075
Drug Design, Development and Therapy; Chanprapaph K, Pomsoong C et. al.

Jan 15th, 2022 - Intramuscular corticosteroids (IMC) have gained popularity for the treatment of severe alopecia areata (AA) in recent years; however, evidence on their efficacy and safety is still limited. To evaluate the efficacy, relapse rate, and tolerability ...

Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review.
https://doi.org/10.1111/dth.15310
Dermatologic Therapy; Benton S, Farah R et. al.

Jan 9th, 2022 - Alopecia areata (AA) is an immune-mediated hair loss disease for which targeted immune treatments including Janus kinase (JAK) inhibitors, for example, tofacitinib, are emerging. More literature is needed on the safety and efficacy of JAK inhibito...

Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis.
https://doi.org/10.2450/2021.0216-21
Blood Transfusion = Trasfusione Del Sangue; Cruciani M, Masiello F et. al.

Dec 31st, 2021 - The number of articles evaluating the efficacy of platelet-rich plasma (PRP) in androgenetic alopecia (AGA) and alopecia areata (AA) has increased exponentially during the last years. This systematic review and meta-analysis is aimed at evaluating...

Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia are...
https://doi.org/10.1016/j.jaci.2021.10.036
The Journal of Allergy and Clinical Immunology; Guttman-Yassky E, Pavel AB et. al.

Dec 6th, 2021 - Janus kinase (JAK) inhibitors have shown encouraging results in the treatment of alopecia areata (AA), an autoimmune form of hair loss, in small, uncontrolled studies and case reports. To conduct a biopsy sub-study during the randomized, double-bl...

Systemic minoxidil as maintenance treatment in alopecia areata: a retrospective case-se...
https://doi.org/10.1111/ced.15051
Clinical and Experimental Dermatology; Moussa A, Bokhari L et. al.

Dec 5th, 2021 - Alopecia areata (AA) is a common, relapsing and remitting, T-cell mediated autoimmune disease.1 Relapse rates are low for patients with disease duration <6 months (13%), moderate for disease duration 6-12 months (65%) and high for disease duration...

see more →

News  18 results

Alopecia Tied to a Threefold Increased Risk for Dementia
https://www.medscape.com/viewarticle/962186

Nov 3rd, 2021 - Alopecia areata (AA), an autoimmune disease that causes hair loss, including baldness, has been linked to a significantly increased risk for dementia, new research shows. After controlling for an array of potential confounders, investigators found...

Pediatric Alopecia Areata in the US Has Increased Twofold Since 2009, Study Finds
https://www.medscape.com/viewarticle/954901

Jul 16th, 2021 - The prevalence of pediatric alopecia areata (AA) in the United States has increased twofold over the past decade and it disproportionately affects females and Hispanic children, according to results from the largest study to date on the topic. "Al...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.staging.medscape.com/viewarticle/930946

May 22nd, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.medscape.com/viewarticle/930946

May 22nd, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

see more →